116 related articles for article (PubMed ID: 6880568)
1. Tubero-infundibular dopaminergic function in cirrhotic patients: evaluation by nomifensine and domperidone.
Monza GC; Lampertico M; Locatelli S; Sali L; Cocchi D
Acta Endocrinol (Copenh); 1983 Jul; 103(3):315-20. PubMed ID: 6880568
[TBL] [Abstract][Full Text] [Related]
2. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
3. Dynamic testing of prolactin and growth hormone secretion in patients with neuroendocrine disorders.
Müller EE; Cavagnini F; Martinez-Campos A; Maraschini C; Giovannini P; Novelli A; De Leo V
Acta Endocrinol (Copenh); 1984 Oct; 107(2):155-63. PubMed ID: 6437104
[TBL] [Abstract][Full Text] [Related]
4. Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia.
Ghigo E; Ciccarelli E; Bianchi SD; Gatti G; Molinatti GM; Massara F; Müller EE; Camanni F
Acta Endocrinol (Copenh); 1986 May; 112(1):20-7. PubMed ID: 3087130
[TBL] [Abstract][Full Text] [Related]
5. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
[TBL] [Abstract][Full Text] [Related]
6. In vivo supersensitivity of the anterior pituitary of old female rats to dopaminergic inhibition of prolactin secretion.
Cocchi D; Novelli A; Ganzetti I; Müller EE
Gerontology; 1984; 30(6):345-9. PubMed ID: 6519436
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hypothalamic dopaminergic function by neuropharmacologic means in aged women.
Cocchi D; Castoldi C; Locatelli S; Novelli A; Colombo AM; Tammaro A; Müller EE
J Neural Transm; 1985; 64(3-4):199-210. PubMed ID: 3003250
[TBL] [Abstract][Full Text] [Related]
8. Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia.
Dallabonzana D; Spelta B; Botalla L; Oppizzi G; Silvestrini F; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1982 Jun; 54(6):1125-8. PubMed ID: 7076795
[TBL] [Abstract][Full Text] [Related]
9. A role for dopamine in growth hormone regulation in the dog.
Casanueva F; Betti R; Cocchi D; Zanardi P; Motta T; Müller EE
Endocrinology; 1981 Apr; 108(4):1469-75. PubMed ID: 7472276
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic neurotransmitter function in experimentally induced hyperprolactinemia.
Peñalva A; Novelli A; Parenti M; Locatelli V; Müller EE; Cocchi D
Brain Res; 1984 Dec; 324(2):233-41. PubMed ID: 6099203
[TBL] [Abstract][Full Text] [Related]
11. Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors.
Cabranes JA; Almoguera I; del Olmo J; Prensa A; Pablos I; Charro AL
J Med; 1986; 17(1):25-39. PubMed ID: 3035040
[TBL] [Abstract][Full Text] [Related]
12. Defective regulation of prolactin secretion after successful removal of prolactinomas.
Camanni F; Ghigo E; Ciccarelli E; Massara F; Campagnoli C; Molinatti G; Müller EE
J Clin Endocrinol Metab; 1983 Dec; 57(6):1270-6. PubMed ID: 6415087
[TBL] [Abstract][Full Text] [Related]
13. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
[TBL] [Abstract][Full Text] [Related]
14. Effects of sustained hyperprolactinemia induced by chronic treatment with domperidone on central dopaminergic systems in the rat.
Benfenati F; Ferretti C; Cimino M; Vantini G; Lipartiti M; Muccioli G; Di Carlo R; Algeri S
Pharmacol Res Commun; 1986 May; 18(5):431-49. PubMed ID: 3737655
[TBL] [Abstract][Full Text] [Related]
15. Persistence of a defective tuberoinfundibular dopaminergic function in rats after long-term removal of oestrogen treatment. An in vivo study.
Cocchi D; Peñalva A; Torpia R; Rossi GL; Müller EE
Acta Endocrinol (Copenh); 1985 Jul; 109(3):309-14. PubMed ID: 4024849
[TBL] [Abstract][Full Text] [Related]
16. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia.
Sekiya K; Karashima T; Ikuyama S; Muta K; Kato K; Ibayashi H
Endocrinol Jpn; 1985 Apr; 32(2):207-14. PubMed ID: 4042986
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
18. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
Mogg RJ; Samson WK
Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
[TBL] [Abstract][Full Text] [Related]
19. Effect of metoclopramide, domperidone and apomorphine on GH secretion in children and adolescents.
Massara F; Tangolo D; Godano A; Goffi S; Bertagna A; Molinatti GM
Acta Endocrinol (Copenh); 1985 Apr; 108(4):451-5. PubMed ID: 3993312
[TBL] [Abstract][Full Text] [Related]
20. Effects of GRF(1-40) and domperidone on GH secretion in normal man.
Giusti M; Mazzocchi G; Sessarego P; Mignone D; Lomeo A; Monachesi M; Giordano G
Clin Endocrinol (Oxf); 1984 Oct; 21(4):339-43. PubMed ID: 6439434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
